ProMIS Neurosciences
PMN
ProMIS Neurosciences (PMN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$1.28
- EPS estimate
- −$1.38
- EPS surprise
- +7.15%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$1.38 | −$1.28 | +7.15% | $0.00 | SEC |
| Q2 2025 | Aug 13, 2025 | −$4.35 | −$7.25 | −66.76% | $0.00 | SEC |
| Q1 2025 | May 12, 2025 | −$3.00 | −$5.25 | −75.00% | $0.00 | SEC |
| Q4 2024 | Mar 31, 2025 | −$3.50 | $3.00 | +185.71% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$1.71 | $7.75 | +553.88% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$3.50 | −$3.25 | +7.14% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$4.98 | −$4.75 | +4.57% | $0.00 | SEC |
| Q4 2023 | Apr 1, 2024 | −$4.13 | −$0.75 | +81.85% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$8.31 | −$4.75 | +42.81% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | $0.00 | −$6.75 | +0.00% | $0.00 | SEC |
| Q1 2023 | May 15, 2023 | $0.00 | −$14.50 | +0.00% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | $0.00 | −$21.25 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did ProMIS Neurosciences (PMN) last report earnings?
ProMIS Neurosciences last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did PMN beat earnings estimates?
Yes. ProMIS Neurosciences reported EPS of −$1.28 for Q2 2026 against a −$1.38 estimate — a 7.15% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.